A Case Series Report on the Effect of Tofacitinib on Joint Inflammation and Gut Microbiota Composition in Psoriatic Arthritis Patients Naive to Biologic Agents
Treatment with tofacitinib proved to be effective, safe and capable of varying the composition of the gut microbiota by selecting bacterial strains considered beneficial in immune modulation.
Authors
- Simonetta Salemi (ORCID: https://orcid.org/0000-0003-4754-8092)
- Concetta Finocchiaro (ORCID: https://orcid.org/0000-0002-8028-5530)
- Roberta Rosa (ORCID: https://orcid.org/0000-0002-6062-8559)
- Andrea Picchianti Diamanti (ORCID: https://orcid.org/0000-0002-8552-4641)
- Concetta Panebianco (ORCID: https://orcid.org/0000-0003-2819-3505)
- Valeria Di Gioia (ORCID: https://orcid.org/0000-0002-6074-0831)
- Gerardo Salerno (ORCID: https://orcid.org/0000-0002-6597-1452)
- Bruno Laganà (ORCID: https://orcid.org/0000-0003-2305-4063)
- Giorgio Sesti (ORCID: https://orcid.org/0000-0002-1618-7688)
- Gabriele Nalli
- Ilaria Anna Bellofatto
Institutions
- Casa Sollievo della Sofferenza (IT)
- University of Genoa (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Microorganisms
- Published
- 2024-11-21
- DOI
- https://doi.org/10.3390/microorganisms12122387
- Citations
- 3
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.41
Funders
- Pfizer